Matinas BioPharma Holdings, Inc. MTNB
0.80 USD -0.01 (-1.26%)
Regular-session close
0.77 -0.03 -3.81%
After hours · Nov 20, 4:00 PM ET
0.7501 Day range 0.80
0.585 52-week range 13.08
- YTD
- +36.50%
- 1 year
- -4.77%
MTNB revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | -1,096,000 | -100.00% |
| FY 2023 | 2023-12-31 | 1,096,000 | -2,092,000 | -65.62% |
| FY 2022 | 2022-12-31 | 3,188,000 | 3,155,000 | 9560.61% |
| FY 2021 | 2021-12-31 | 33,000 | 33,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-03T06:02:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
